InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
9
Disclosed sells
2
T+90 hit rate
80%
T+90 mean return
+10.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Chen Bihua. Insider active across 7 companies, notably Erasca, Inc.. Cumulatively, 23 reports have been published. Breakdown: 9 buys · 2 sells. Total volume traded: €75.3m. History available since 26 July 2021. The latest transaction was disclosed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Chen Bihua
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0001231919-26-000852:2
Canonical exit: 8 Nov 2026 (T+90)
1,599,993 sharesCommon StockSEC:0001231919-26-000852:0
1,701,541 sharesCommon StockSEC:0001231919-26-000852:1
2,692,459 shares0Common StockSEC:0001213900-26-075538:1
1,704,862 shares0Common StockSEC:0001213900-26-075538:2
130,865 shares0Common StockSEC:0001213900-26-075538:3
4,528,186 shares0Common StockSEC:0001213900-26-075538:0
497,500 shares@ US$10.0050.0% of flowClass A Ordinary SharesSEC:0001213900-26-009021:0
497,500 shares@ US$10.0050.0% of flowClass A Ordinary SharesSEC:0001213900-26-007772:0
70,748 shares@ US$9.381.1% of flowClass A Ordinary SharesSEC:0000929638-25-003712:0
4,172,126 sharesCommon StockSEC:0001213900-25-075305:0
509,000 shares@ US$10.00100.0% of flowClass A Ordinary SharesSEC:0001213900-24-013534:0
58,839 shares@ US$59.89736.4% of flowClass A Ordinary SharesSEC:0000929638-23-002739:0
Canonical exit: 3 Jan 2024 (T+90)
74,911 shares@ US$57.377.8% of flowClass A Ordinary SharesSEC:0000929638-23-002692:0
Canonical exit: 31 Dec 2023 (T+90)
800,000 shares@ US$50.0070.2% of flowClass A Ordinary SharesSEC:0000929638-23-001943:0
Canonical exit: 28 Sept 2023 (T+90)
1,481 shares@ US$36.910.1% of flowClass A Ordinary SharesSEC:0000929638-23-001857:0
Canonical exit: 24 Sept 2023 (T+90)
400,000 shares@ US$30.00100.0% of flowCommon StockSEC:0000929638-23-001057:0
Canonical exit: 28 Jun 2023 (T+90)
446,881 shares@ US$19.363915.5% of flowClass A Ordinary SharesSEC:0000929638-23-000895:0
Canonical exit: 18 Jun 2023 (T+90)
307,692 shares@ US$6.5018.7% of flowCommon StockSEC:0000929638-22-001904:0
Canonical exit: 13 Mar 2023 (T+90)
307,692 shares@ US$6.5018.7% of flowCommon StockSEC:0000929638-22-001901:0
Canonical exit: 13 Mar 2023 (T+90)
2,785,000 shares0Class A Ordinary SharesSEC:0001213900-22-018749:0
200,000 shares@ US$18.76562.6% of flowCommon StockSEC:0001567619-21-014882:0
9,555,553 sharesCommon StockSEC:0001567619-21-013838:0
23 of 23 declarations
About Chen Bihua
Chen Bihua has 20 filings in total. In the 20 sampled recent filings, total buy volume is EUR 67199627 and total sell volume is EUR 3744089, across the period from 2021-07-22 to 2026-07-06. The companies involved include MoonLake Immunotherapeutics, BridgeBio Oncology Therapeutics, Inc., Erasca, Inc., Helix Acquisition Corp. III, Helix Acquisition Corp. II, and Biomea Fusion, Inc., with roles listed for some of them, including Director, Chairperson and CEO, and CEO and Chairperson.
